These UK-led efforts come after the US pulled foreign research aid to focus on its domestic health agenda.

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more risk‑proportionate approach and place transparency obligations on a clear ...

The UK’s National Health Service (NHS) has been awarded £47.8m ($63.8m) from the National Institute for Health and Care Research (NIHR) to pay for equipment that will increase the NHS’s ability to ...

Explore the latest NHS funding announcement of nearly £50 million to enhance research capabilities across England ...

In an effort to boost global biopharma competitiveness, the U.K.’s National Institute for Health and Care Research (NIHR) has ...

Last week the Regulation on Clinical Trials (“CTR”) finally became effective in the European Union (“EU”) and replaced the prior Clinical Trials Directive 2001/20 (“CTD”). The CTR was adopted in 2014 ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced several new measures to make it easier to run clinical trials in the country, marking the first time in 20 years ...

One of the country's first nurses dedicated to dementia research has been appointed in Sheffield to help build on knowledge ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

The government has appointed Lord James O'Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK), and former Health Minister, to conduct ...